Lombard Odier Asset Management (USA) Corp - CYMABAY THERAPEUTICS INC ownership

CYMABAY THERAPEUTICS INC's ticker is CBAY and the CUSIP is 23257D103. A total of 27 filers reported holding CYMABAY THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Lombard Odier Asset Management (USA) Corp ownership history of CYMABAY THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$284,000
-61.7%
145,0000.0%0.02%
-64.8%
Q3 2019$742,000
-28.5%
145,0000.0%0.07%
-15.5%
Q2 2019$1,038,000
-56.6%
145,000
-19.4%
0.08%
-57.1%
Q1 2019$2,390,000
+38.4%
180,000
-18.0%
0.20%
+44.1%
Q4 2018$1,727,000
-47.7%
219,495
-26.4%
0.14%
-43.8%
Q3 2018$3,303,000
-35.1%
298,061
-21.4%
0.24%
-27.3%
Q2 2018$5,086,000
-3.1%
379,000
-6.2%
0.33%
-11.9%
Q1 2018$5,248,000
+9.4%
404,000
-22.5%
0.38%
+2.7%
Q4 2017$4,795,000
+13.3%
521,247
-0.7%
0.37%
+22.3%
Q3 2017$4,232,000
+39.5%
525,000
-0.3%
0.30%
+25.4%
Q2 2017$3,034,000
+34.0%
526,6650.0%0.24%
+12.7%
Q1 2017$2,265,000
+127.0%
526,665
-8.7%
0.21%
+67.7%
Q4 2016$998,000
-17.9%
576,665
-8.0%
0.13%
+13.4%
Q3 2016$1,216,000
+6.9%
626,978
-4.0%
0.11%
-18.8%
Q2 2016$1,137,000
+18.7%
653,216
-7.9%
0.14%
+6.2%
Q1 2016$958,000
-47.8%
709,440
-34.7%
0.13%
-27.0%
Q4 2015$1,835,000
-13.9%
1,085,681
-1.1%
0.18%
-4.3%
Q3 2015$2,131,000
+6.8%
1,098,198
+48.0%
0.19%
+31.0%
Q2 2015$1,996,000
-78.0%
742,126
-43.4%
0.14%
-80.4%
Q1 2015$9,072,000
-32.6%
1,311,000
-4.2%
0.72%
-21.6%
Q4 2014$13,453,000
+57.3%
1,368,557
+9.5%
0.92%
+56.3%
Q3 2014$8,550,0001,250,0000.59%
Other shareholders
CYMABAY THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Foresite Capital Management III, LLC 1,641,804$7,454,0006.54%
COMMODORE CAPITAL LP 2,983,513$13,545,0005.40%
Foresite Capital Management IV, LLC 1,787,094$8,113,0000.97%
Avoro Capital Advisors LLC 10,300,000$46,762,0000.81%
Boxer Capital, LLC 4,000,000$18,160,0000.62%
Sio Capital Management, LLC 562,339$2,553,0000.52%
ACUTA CAPITAL PARTNERS, LLC 315,341$1,432,0000.52%
CM Management, LLC 150,000$681,0000.51%
APIS CAPITAL ADVISORS, LLC 120,000$545,0000.50%
Versant Venture Management, LLC 543,753$2,469,0000.48%
View complete list of CYMABAY THERAPEUTICS INC shareholders